BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10063346)

  • 1. Tuberculosis in patients infected with the human immunodeficiency virus.
    Gerard M
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):688-92. PubMed ID: 10063346
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis.
    Boyd MA; Burger DM; Phanuphak P; Cooper DA
    AIDS; 2006 Apr; 20(7):1083-5. PubMed ID: 16603870
    [No Abstract]   [Full Text] [Related]  

  • 3. Management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis. TB/HIV Advisory Committee.
    Can Commun Dis Rep; 1998 May; 24(10):77-80. PubMed ID: 9613030
    [No Abstract]   [Full Text] [Related]  

  • 4. Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients.
    Schluger NW
    Clin Infect Dis; 1999 Jan; 28(1):130-5. PubMed ID: 10028083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration.
    Whalen C; Okwera A; Johnson J; Vjecha M; Hom D; Wallis R; Huebner R; Mugerwa R; Ellner J
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1977-81. PubMed ID: 8665064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rifamycins in HIV-infected patients.
    Preboth M
    Am Fam Physician; 2000 Sep; 62(5):1189-90. PubMed ID: 10997538
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on treatment and prevention guidelines for HIV-related tuberculosis.
    Chaisson RE
    Hopkins HIV Rep; 1999 May; 11(3):3,10,12. PubMed ID: 11367371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOH reviews HIV/TB treatment protocols.
    Bateman C
    S Afr Med J; 2008 Nov; 98(11):838, 840. PubMed ID: 19177885
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
    Pulido F; Iribarren JA; Kindelan JM; Moreno S
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV: opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
    [No Abstract]   [Full Text] [Related]  

  • 11. Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
    Dierberg KL; Chaisson RE
    Clin Chest Med; 2013 Jun; 34(2):217-28. PubMed ID: 23702172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of tuberculosis in HIV-infected patients.
    Nahid P; Daley CL
    Curr Opin Infect Dis; 2006 Apr; 19(2):189-93. PubMed ID: 16514345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC calls for tuberculosis screening and treatment for all patients with HIV infection.
    Rose VL
    Am Fam Physician; 1999 Mar; 59(6):1682, 1687. PubMed ID: 10193602
    [No Abstract]   [Full Text] [Related]  

  • 14. Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy.
    Martínez E; Miró JM; González J; Mallolas J; Gatell JM
    AIDS; 1999 Jan; 13(1):147-8. PubMed ID: 10207565
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV and tuberculosis.
    Sharma SK; Ahluwalia G
    Indian J Chest Dis Allied Sci; 2000; 42(2):77-81. PubMed ID: 10916271
    [No Abstract]   [Full Text] [Related]  

  • 16. [Miliary pattern in an HIV infected patient on tuberculostatic therapy. Paradoxical reaction of tuberculosis during antiretroviral therapy].
    del Pino Cuadrado J; Racionero Casero MA; Artacho Tejederas JR; Colomina Avilés J
    Rev Clin Esp; 2001 Apr; 201(4):219-20. PubMed ID: 11447912
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversial topics in tuberculosis.
    Caminero JA; Torres A
    Eur Respir J; 2004 Dec; 24(6):895-6. PubMed ID: 15572527
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART.
    Zanoni BC; Phungula T; Zanoni HM; France H; Feeney ME
    AIDS; 2011 Jan; 25(1):49-55. PubMed ID: 20935555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011.
    Pozniak AL; Coyne KM; Miller RF; Lipman MC; Freedman AR; Ormerod LP; Johnson MA; Collins S; Lucas SB;
    HIV Med; 2011 Oct; 12(9):517-24. PubMed ID: 21951595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.